Control Bionics is quickly becoming the world’s leading provider of wearable, EMG devices. Their latest Trilogy product line provides a solution uniquely designed for those living with motor impairment and speech difficulties due to conditions like MND, SCI, TBI, and Cerebral Palsy. The NeuroNode Trilogy and GridPad Trilogy provide users with three unique access methods, allowing for faster communication speed and lower fatigue with a single, lifetime solution. Control Bionics’ industry leading client commitment and cutting-edge technology are changing lives across the world – from classrooms in the United States to rehab facilities in Australia.
Follow us on Twitter @Control_Bionics, or on Facebook @ControlBionics.